Skip to content

Global Reference Ranges - Singapore

Global Reference Ranges - Singapore

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07166471
Acronym
GRR Singapore
Enrollment
50
Registered
2025-09-10
Start date
2026-01-01
Completion date
2027-09-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Participants

Brief summary

We aim to undertake the Global Reference Range Study (GRR) to establish a set of healthy adult reference values for measures of fibroinflammation, fat and size/volumes for the liver, and other abdominal and thoracic organs to assess, compare, and if necessary, propose ethnicity specific reference ranges for these measurements.

Interventions

None listed

Sponsors

Perspectum
Lead SponsorINDUSTRY
National Heart Centre Singapore
CollaboratorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Male or female at least 18 years of age * Self-reported healthy * Willing and able to give informed consent for participation in the study * Willing and able to undergo an MRI

Exclusion criteria

* History of cardiovascular disease as follows: * Myocardial infarction * Heart failure * Cardiomyopathy * Stroke * Hospital admission/discharge for unstable angina * Heart surgery * Unstable angina * Transient ischemic attack * Presence of CVD risk factors such as hypertension, hyperlipidaemia, Type 2 diabetes, BMI \> 30 kg/m2, smoker (current/ex-smoker) * History of non-cardiac diseases related to the lungs, liver, kidneys, pancreas or spleen judged by the study investigator as therefore unsuitable to participate in the study * The participant may not enter the study if they have any contraindication to magnetic resonance imaging (standard MRI

Design outcomes

Primary

MeasureTime frame
To determine the reference values for liver fibroinflammation in healthy adults from different ethnic groups.24 months

Countries

Singapore

Contacts

CONTACTMasliza Mahmod
masliza.mahmod@perspectum.com001865655343
STUDY_CHAIRRavi Pattanshetty

Perspectum

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026